Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anodyne Therapy is a medical device company specializing in Monochromatic Infrared Photo Energy (MIRE) technology. The company's primary products are non-invasive infrared light therapy systems designed to increase local circulation and reduce pain. These devices are frequently used in clinical settings and at home for patients suffering from peripheral neuropathy, particularly those with diabetes. The technology works by emitting near-infrared light at a specific wavelength that promotes the release of nitric oxide from hemoglobin. Anodyne's systems are FDA-cleared and have been the subject of numerous peer-reviewed clinical studies. The company serves a variety of healthcare providers, including physical therapists, podiatrists, and wound care specialists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anodyne Therapy.